U.S. Infrastructure Stock News

Lowe's Companies stock has delivered a 15.4% gain over the past five years, yet its current valuation picture is more balanced, with the Discounted Cash Flow (DCF) intrinsic value estimate indicating the shares are roughly in line with fair value while earnings-based multiples lean more supportive. Over five years, a 15.4% total return suggests Lowe's Companies has rewarded patient shareholders, although the path has included periods of weaker performance. Future expectations for cash...

Devon Energy (NYSE:DVN) has approved moving ahead with the Solitude Pipeline System joint venture with WhiteWater and other partners to move natural gas from the Permian Basin to the Katy, TX hub and Gulf Coast. The multi phase project is designed to expand gas takeaway capacity from the Permian and link Devon volumes to Gulf Coast LNG export and power generation markets. The Solitude Pipeline System is expected to integrate with Devon Energy's existing infrastructure platform and influence...

In recent months, Zoom Video Communications has reported solid quarterly results and launched its US$20-per-user-per-month ZoomMate AI work surface, even as billings growth and net revenue retention of 99% have highlighted softer customer expansion and demand. This mix of resilient performance, expanding AI-powered offerings, and signs of slowing momentum has sharpened debate over whether current valuation signals opportunity or future pressure on growth and margins. We’ll now examine how...

Galaxy Digital has just delivered a very large 3 year return, while the share price over the past year has declined and the valuation checks point to a mixed picture rather than a clear bargain or clear overvaluation. Galaxy Digital has returned roughly 7x over 3 years, which puts recent share price weakness in a very different context for anyone looking at longer holding periods. Progress in crypto infrastructure partnerships, such as the recently announced role providing trading and...

StoneCo Ltd. has reported past second-quarter 2026 results, with revenue increasing slightly to R$3,587.38 million while net income declined to R$444.59 million versus a year earlier. Over the first half of 2026, StoneCo’s revenue grew modestly but net income more than doubled to R$2.15 billion, highlighting the impact of non-recurring items and credit provisioning. We’ll now examine how StoneCo’s expanding but pressured credit portfolio could influence its existing investment narrative and...

Earlier in 2026, Vicor raised its full‑year revenue outlook to more than US$600 million and guided to nearly 10% sequential third‑quarter revenue growth, citing strong operating momentum and improving visibility into AI‑related power‑delivery demand. The company also moved ahead with plans for a second fabrication facility designed to roughly double current production capacity, underscoring management’s confidence that AI computing requirements could support significantly higher long‑term...

Hormel Foods (NYSE:HRL) has introduced a co-branded premium chili in partnership with Omaha Steaks, combining both companies' branding in a new convenience offering. The company is also rolling out a PLANTERS seasonal fall snack collection, featuring a mix of new and returning limited-time flavors. Both launches target demand for higher-quality convenient meals and seasonal snacking, aiming to deepen customer engagement with Hormel Foods' core brands. Consider exploring other consumer...

Artisan Partners Asset Management has recently paid a total dividend of US$0.80 per share, following an ex-dividend date of 17 August 2026, extending a dividend record that dates back to 2013. While the dividend offers a high yield appealing to income-focused investors, the payout ratio of 1.03 indicates the company is distributing more than its earnings, raising questions about how reliable this income stream may be over time. Next, we'll examine how concerns around an above-earnings...

Johnson & Johnson (JNJ) stock is in focus after FDA clearance of the MONARCH QUEST 3 bronchoscopy system, along with momentum in its Innovative Medicine segment despite ongoing STELARA biosimilar headwinds. See our latest analysis for Johnson & Johnson. At a share price of $262.37, Johnson & Johnson has a 90 day share price return of 14.07% and a year to date share price return of 26.53%. The 1 year total shareholder return of 52.58% points to strong recent momentum building around products...

On August 10, 2026, The Accountability Board submitted a shareholder proposal asking Darden Restaurants to adopt and disclose a policy requiring a formal board review and public summary whenever a director in an uncontested election receives support below 80%, following which Darden urged investors to vote against the measure in its September 23, 2026 annual meeting materials. This governance-focused clash arrives just after Darden reported strong fiscal Q4 2026 sales growth and analysts...

Recent developments in the field of Cloud AI highlight a significant leap from experimental technology to a core component of economic infrastructure, driven by substantial private and public investments. A newly published report by BCC Research reveals that global AI investments reached $194 billion, with the U.S. leading in venture capital contributions, thus emphasizing the escalating global race for AI leadership. Enterprise adoption rates are rising, particularly in sectors like BFSI,...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Bristol-Myers Squibb stock has delivered a 40.6% 1 year return, while both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount to what the business may be worth. The 40.6% gain over the past year suggests sentiment has improved, yet current valuation signals still indicate the market price may be below intrinsic value. Recent FDA accelerated approval for ZENBEXUS can support expectations for future cash flows, while...

US$166b in tariff refunds plus interest is quietly reshaping corporate cash piles, at the same time that fresh trade barriers and a wider US fiscal deficit keep markets on edge. That mix of extra liquidity and higher risk is creating potential winners among financial stocks that sit closest to new corporate cash. This article unpacks the tariff story and highlights three stocks exposed to these refunds that investors may want to keep on their radar. The sample stocks covered below are just a...

Crinetics Pharmaceuticals has delivered a very strong share price run over the past three years, yet its current valuation screens as expensive on market multiples and the broader checks only give it a mixed score. That combination leaves investors weighing a powerful recent return against signals that the stock is not clearly cheap at today’s price of US$84.75. Crinetics Pharmaceuticals has returned 428.0% over the past three years, which sets a high bar for any further gains to be...

Why Hesai Group Stock Is Back In Focus After Q2 Results Hesai Group (HSAI) drew fresh attention after reporting second quarter 2026 results, with higher sales and net income for both the quarter and first half of the year compared with 2025. See our latest analysis for Hesai Group. Hesai Group's earnings release comes after a strong 30 day share price return of 20.47%. However, the share price is still down 24.96% year to date and the 1 year total shareholder return has declined 32.12%, while...

Earlier this month, Health Canada authorized Moderna to begin a Phase I clinical trial of its mRNA Bundibugyo Ebola vaccine candidate, while the U.S. FDA recently approved mFlusiva as the first mRNA flu vaccine for adults aged 50 and older, including accelerated approval for those 65 and above. This pairing of an early-stage Ebola program with full U.S. approval for an mRNA flu shot highlights how Moderna is extending its mRNA platform beyond COVID-19 into both seasonal and outbreak-driven...

Mueller Industries stock has delivered a very large 5 year return, yet its valuation checks now point to a more balanced picture where the Discounted Cash Flow (DCF) intrinsic value estimate looks close to the current share price while market multiples still lean on the cheap side. Mueller Industries has returned about 5.4x over 5 years, which puts extra focus on whether the current price already reflects much of that success. Future cash flow from its manufacturing operations can support...

Molson Coors Beverage (TAP) drew investor attention on 6 August 2026 after reporting softer second quarter and six month earnings, with lower sales and net income compared with the same periods a year earlier. See our latest analysis for Molson Coors Beverage. Molson Coors Beverage shares have come under pressure around the earnings release, with a 1 day share price return of down 4.75% and year to date share price return of down 14.05%. The 3 year total shareholder return of down 28.08%...

With the 30 year U.S. Treasury yield near a 19 year high, income investors are suddenly competing with bonds that pay more for taking less risk. That shift can pressure many stocks, yet it also helps reveal which dividend payers look built to handle tougher financial conditions. This article walks through three stocks from a High Quality Dividend Value screener that appear especially sensitive to this new rate reality. The three stocks below are just a starting sample from this approach,...

Climb Bio, Inc. reported second quarter and six‑month 2026 results, with a net loss of US$13.5 million for the quarter and US$27.22 million for the first half, and higher quarterly loss per share year over year but lower loss per share over six months. The figures highlight a mixed picture for investors, with quarterly losses widening while year‑to‑date losses and loss per share improved compared with 2025. Next, we’ll examine how Climb Bio’s widening quarterly loss but improving...

Karman Holdings earnings, guidance and financing moves in focus Karman Holdings (KRMN) is in focus after second quarter 2026 results, updated full year revenue guidance and a refinancing of its credit facilities that changes the cost of its existing debt structure. See our latest analysis for Karman Holdings. Karman Holdings' latest earnings, raised revenue guidance and credit agreement amendment come after a period where the share price has been volatile. The stock has a 1 month share price...

NextDecade (NEXT) has drawn investor attention after recent share price moves, with the stock closing at $6.95 on 18 August 2026. The company focuses on US liquefied natural gas export and carbon capture projects. See our latest analysis for NextDecade. Against that backdrop, NextDecade’s share price has pulled back in the short term, with a 30 day share price return down 9.51% and a 90 day share price return down 22.52%, while the year to date share price return of 29.18% contrasts with a 1...

Newmark Group, Inc. announced that long-serving CEO Barry Gosin, in the role since 1979, will step down on December 31, 2026, while remaining Chairman of Newmark & Company Real Estate, Inc. to support a smooth leadership transition. This leadership change comes as Newmark shows resilience in commercial real estate, with growing management services, leasing, and capital markets businesses despite broader sector challenges. Next, we’ll examine how Gosin’s planned CEO handover could influence...